These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14999119)

  • 1. Nonsurgical treatment of laryngeal cancer.
    Weinstein GS; Myers EN; Shapshay SM; Weber R
    N Engl J Med; 2004 Mar; 350(10):1049-53; author reply 1049-53. PubMed ID: 14999119
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonsurgical treatment of laryngeal cancer.
    Langer M
    N Engl J Med; 2004 Mar; 350(10):1049-53; author reply 1049-53. PubMed ID: 15002116
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonsurgical treatment of laryngeal cancer.
    Guntinas-Lichius O
    N Engl J Med; 2004 Mar; 350(10):1049-53; author reply 1049-53. PubMed ID: 15002118
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonsurgical treatment of laryngeal cancer.
    Gupta T; Agarwal J; Lashkar SG
    N Engl J Med; 2004 Mar; 350(10):1049-53; author reply 1049-53. PubMed ID: 15002115
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of laryngeal cancer: the permanent challenge.
    Lefebvre JL; Coche-Dequéant B; Degardin M; Kara A; Mallet Y; Ton Van J
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):913-20. PubMed ID: 15485324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic options for laryngeal cancer.
    Vokes EE; Stenson KM
    N Engl J Med; 2003 Nov; 349(22):2087-9. PubMed ID: 14645634
    [No Abstract]   [Full Text] [Related]  

  • 7. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acral metastases from laryngeal carcinoma.
    Nayak J; Zhong Y; Haigentz M
    J Clin Oncol; 2011 Mar; 29(9):e220-1. PubMed ID: 21189398
    [No Abstract]   [Full Text] [Related]  

  • 9. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation.
    Hanna E; Sherman A; Cash D; Adams D; Vural E; Fan CY; Suen JY
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):875-9. PubMed ID: 15262766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative assessment of the five-year results of surgical, combined, radiation and chemoradiotherapy in laryngeal cancer (T3N0M0)].
    Tkachëv SI; Matiakin EG; Liubaev VL; Boĭkov VP; Alieva SB; Aliev BM; Kondrat'eva AP; Aketova TA; Pirogova NA; Loginova IN
    Vopr Onkol; 2006; 52(4):404-7. PubMed ID: 17024811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ preservation surgery for laryngeal cancer.
    Tufano RP; Stafford EM
    Otolaryngol Clin North Am; 2008 Aug; 41(4):741-55, vi. PubMed ID: 18570956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy for larynx preservation: patient selection or therapeutic effect?
    Pfister DG; Ridge JA
    J Clin Oncol; 2006 Feb; 24(4):540-3. PubMed ID: 16380409
    [No Abstract]   [Full Text] [Related]  

  • 14. Concurrent chemotherapy and radiation therapy reduce laryngectomy rates.
    Hitt E
    Lancet Oncol; 2002 Dec; 3(12):709. PubMed ID: 12473495
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
    Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
    Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
    Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
    J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsurgical treatment of laryngeal cancer.
    Haddad RI; Tishler RB; Posner MR
    N Engl J Med; 2004 Mar; 350(10):1049-53; author reply 1049-53. PubMed ID: 15002117
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary: phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concurrent chemotherapy and radiotherapy versus radiotherapy--intergroup trial R91-11.
    Wolf GT
    J Clin Oncol; 2001 Sep; 19(18 Suppl):28S-31S. PubMed ID: 11560968
    [No Abstract]   [Full Text] [Related]  

  • 19. [In patients with cancer of the larynx, chemoradiotherapy with cisplatin is superior to neoadjuvant chemotherapy followed by radiotherapy and to exclusive radiotherapy].
    Racadot S; Mazeron JJ
    Bull Cancer; 2004 Mar; 91(3):211-2. PubMed ID: 15171045
    [No Abstract]   [Full Text] [Related]  

  • 20. Searching for less toxic larynx preservation: a need for common definitions and metrics.
    Forastiere AA; Trotti AM
    J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.